QQ客服 官方微博 反馈留言

浏览/检索结果: 共17条，第1-10条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 7 作者:  Gong, Xiaomei;  Li, Xuefei;  Jiang, Tao;  Xie, Huikang;  Zhu, Zhengfei 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Programmed death ligand 1  Radiation resistance  Tumor-infiltrating regulatory T cells  Myeloid-derived suppressor cells  PI3K/AKT pathway   PROGNOSTIC VALUE OF PROGRAMMED DEATH LIGAND 1 EXPRESSION IN OVARIAN CLEAR CELL CARCINOMA 会议论文 作者:  Zhu, J. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer 期刊论文 JOURNAL OF THORACIC DISEASE, 2017, 卷号: 9, 期号: 8 作者:  Pan, Yunjian;  Zheng, Difan;  Li, Yuan;  Cai, Xu;  Zheng, Zongli 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Programmed death ligand 1 expression (PD-L1 expression)  non-small cell lung cancer (NSCLC)  survival   PROGNOSTIC VALUE OF PROGRAMMED DEATH LIGAND 1 EXPRESSION IN OVARIAN CLEAR CELL CARCINOMA 会议论文 作者:  Zhu, J. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Evidence of Interleukin 21 Reduction in Osteosarcoma Patients Due to PD-1/PD-L1-Mediated Suppression of Follicular Helper T Cell Functionality 期刊论文 DNA AND CELL BIOLOGY, 2017, 卷号: 36, 期号: 9 作者:  Gao, Wenwu;  Zhou, Junjie;  Ji, Bin 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 interleukin 21  osteosarcoma  programmed death ligand 1   Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis 期刊论文 MEDICINE, 2017, 卷号: 96, 期号: 44 作者:  Sun, Xiaoying;  Roudi, Raheleh;  Chen, Shangya;  Fan, Bin;  Li, Hong Jin 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 immune-related adverse events  inhibitors  meta-analysis  nonsmall cell lung cancer  programmed cell death protein-1  programmed death-ligand 1  systematic review   Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy 期刊论文 JOURNAL OF OVARIAN RESEARCH, 2017, 卷号: 10 作者:  Li, Mengjiao;  Li, Haoran;  Liu, Fei;  Bi, Rui;  Tu, Xiaoyu 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Ovarian clear cell carcinoma  Immunohistochemistry  Chemoresistance  Aurora kinase A  Programmed death ligand-1   Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma 期刊论文 JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 卷号: 28, 期号: 6 作者:  Zhu, Jun;  Wen, Hao;  Bi, Rui;  Wu, Yong;  Wu, Xiaohua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Ovarian Neoplasms  Adenocarcinoma  Clear Cell  Antigens  CD274  Prognosis   The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma 期刊论文 MEDICINE, 2017, 卷号: 96, 期号: 15 作者:  Yang, Zhizhang;  Qiu, Weizhe;  Zhang, Long;  Zhang, Suxia;  Wu, Yunjin 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 diffuse large B-cell lymphoma  programmed cell death 1  programmed cell death ligand 1  TP63   Prognostic value of PD-L1 expression in non-small cell lung cancer: A meta-analysis 期刊论文 International Journal of Clinical and Experimental Medicine, 2017, 卷号: 10, 页码: 8735-8744 作者:  Fan, Yangwei;  Ma, Ke;  Hu, Yuan;  Niu, Wenxia;  Li, Enxiao 收藏  |  浏览/下载：5/0  |  提交时间：2019/11/26 Clinicopathological parameters  Meta-analysis  Non-small cell lung cancer  Overall survival  Prognosis  Programmed death ligand-1